|
|
Article: CardioNet Awarded its 15th U.S. Patent.
- Article from:
- Business Wire
- Article date:
- October 28, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Newest Patent for Biological Signal Management
CONSHOHOCKEN, Pa. -- CardioNet, Inc. (NASDAQ: BEAT) announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry[TM] (MCOT[TM]) system that automatically processes complex physiological information to make it useful for clinical decisions. This is the 15th U.S. Patent that has been issued to CardioNet.
Randy Thurman, CardioNet Chairman, President and CEO, commented, "A key to success in delivering wireless medicine is ...